Genomic profiling helps assess melanoma risk by analyzing microRNA expressions in lesions. Researchers create a scoring system for malignancy by identifying microRNA signatures, aiming to standardize diagnostics. #MelanomaAwareness #GenomicTesting #SkinHealth

MicroRNAs influence gene activity and their disruption in melanoma aids cancer growth. This forms a molecular fingerprint separating melanoma from benign moles. Tracking these changes can enable earlier, precise diagnoses. #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine

Genetic markers in moles unveil melanoma insights. Small molecules show severity; genomic tech detects RNA shifts, aiding early cancer detection. Result? Greater accuracy in diagnosis with 'molecular profiles.' #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine

Great response from the media to our announcement this week. Melaseq is the first diagnostic test for melanoma that was entirely designed, validated and approved in Australia! 🇦🇺 ☀️ 🧪